论文部分内容阅读
文献报告肝硬化合并肝细胞癌(HCC)病人手术治疗死亡率高、复发率高和存活率低。为了评价肝硬化合并HCC病人手术治疗效果,作者进行了前瞻性研究。 1989年 10月～1994年 3月对肝硬化合并HCC病人代例施行肝切除术,男34例,女14例,年龄44～71岁,平均62岁,肝硬化原因:HBV感染6例,HCV感染26例,原因不明9例,酒精中毒性6例,原发性胆囊硬化引起1例。 AFP正常22例,>100mg/ml7例。术前只发现孤立性肿块且小于5cm。手术方法:凡 1个肿块且< 5cm者施行分段切
The literature reports that patients with cirrhosis combined with hepatocellular carcinoma (HCC) have a high mortality rate, a high recurrence rate, and a low survival rate. In order to evaluate the efficacy of surgical treatment of cirrhosis patients with HCC, the authors conducted a prospective study. From October 1989 to March 1994, liver resection was performed on cirrhosis patients with HCC. There were 34 males and 14 females aged 44-71 years with an average age of 62 years. The causes of cirrhosis were: HBV infection in 6 cases, HCV Twenty-six cases were infected. There were 9 unexplained cases, 6 cases of alcohol toxicity, and 1 case of primary gallbladder hardening. AFP was normal in 22 cases and >100 mg/ml in 7 cases. Only isolated solitary masses were found before surgery and were less than 5 cm. Surgical methods: Where a lump and < 5cm are divided into sections